Ciprocure

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ciprocure

Quick Facts

Property Description
Active ingredient Ciprofloxacin
Form Tablet, Solution, Suspension, Drops
Pharmacological class Fluoroquinolone Antibiotic
Common purpose To kill susceptible bacteria
Origin Synthetic

What is Ciprocure and What Class of Antibiotic is it?

Ciprocure is a prescription-only medication identified by its active pharmaceutical ingredient, Ciprofloxacin, a powerful, synthetic antibiotic substance. It is classified as an antimicrobial agent belonging to the fluoroquinolone group of antibiotics, specifically recognized as a second-generation fluoroquinolone. The compound is utilized in antibacterial protocols worldwide.

This classification defines its intended role: to combat infections caused by susceptible bacteria. As a synthetic compound, Ciprofloxacin is engineered to perform a distinct action compared to naturally derived antibiotics, ensuring its effectiveness against a broad-spectrum of microorganisms. Its status as a prescription-only drug underscores its potency and specific therapeutic use, making it a common choice for bacterial infections in adults.


Composition and General Purpose of the Drug

The composition of Ciprocure is based on the single active ingredient, Ciprofloxacin, which is typically present as Ciprofloxacin hydrochloride or Ciprofloxacin betaine. The drug’s general purpose is to exert a direct bactericidal effect, meaning it actively kills the bacteria responsible for infection rather than merely inhibiting their growth.

To allow for precise targeting of infection, Ciprofloxacin is prepared in diverse forms, including conventional and extended-release tablets, oral suspensions, sterile solutions for infusion (for Intravenous administration), and specialized ophthalmic or otic drops for localized treatment. This variety of forms ensures the core antibacterial action of this agent can be delivered across diverse administration routes to clear the bacterial population and support the patient’s recovery.

What side effects are possible with Ciprocure?

Serious Adverse Reactions and Safety Restrictions

Ciprocure (Ciprofloxacin) is a fluoroquinolone antibiotic associated with the risk of disabling, long-lasting, and potentially irreversible serious adverse reactions affecting multiple body systems. Regulatory agencies, including the FDA and EMA, have issued stringent warnings, often in the form of a Boxed Warning, to address these risks.

Key serious adverse events, which can occur within hours to weeks of treatment initiation or months after discontinuation, primarily involve:

  • Musculoskeletal System: Tendinitis, leading to inflammation and swelling, and potentially tendon rupture, most commonly affecting the Achilles tendon. The risk is higher in patients over 60, those with renal impairment, and those taking systemic corticosteroids.
  • Nervous System: Peripheral neuropathy (nerve damage) leading to symptoms like numbness, tingling, burning pain, or weakness in the hands and feet. This effect may become permanent. Central Nervous System (CNS) effects such as seizures, confusion, hallucinations, and serious changes in mood or behavior, including suicidal thoughts, are also documented.
  • Cardiovascular System: Cases of aortic aneurysm or dissection (a tear in the wall of the main artery) and heart valve regurgitation have been reported, necessitating careful use in at-risk patients.

Common Side Effects and Usage Limitations

The most common adverse reactions reported are generally gastrointestinal, including nausea, diarrhea, vomiting, and stomach pain. Headache and abnormal liver function tests are also frequently documented.

Due to the severity of the potentially irreversible side effects, regulatory restrictions stipulate that Ciprocure should be reserved for approved indications where no alternative treatment options are available. Treatment must be discontinued immediately if the patient experiences the first signs of tendon pain, inflammation, or symptoms of neuropathy, to help mitigate the risk of developing potentially long-lasting complications.

Overdose and Emergency Response

If you suspect an overdose of Ciprocure (ciprofloxacin), you must seek emergency medical attention immediately. Overdose can lead to various serious side effects, including some that affect the kidneys. While specific symptoms can vary, general signs of a significant overdose may involve worsening known side effects.

Immediate medical help is required if you experience any of the following serious symptoms, as they may indicate a severe reaction or overdose:

  • Seizures or convulsions.
  • Severe and persistent stomach, chest, or back pain.
  • Fainting, severe dizziness, or confusion.
  • Any signs of an allergic reaction, such as hives, swelling of the face, tongue, or throat, or trouble breathing.
  • Symptoms of severe peripheral neuropathy, which includes persistent or worsening numbness, tingling, burning pain, or weakness in the hands or feet.

Overdose Symptoms and Potential Effects

System Affected Potential Symptoms/Effects
Gastrointestinal Severe nausea and vomiting, diarrhea
Nervous System Dizziness, headache, confusion, tremors, hallucinations, seizures
Renal (Kidneys) Signs of acute renal failure (though less common, this is a serious risk)

If an overdose is confirmed, standard management usually involves immediate supportive care and measures to remove the unabsorbed drug. Do not induce vomiting or wait for symptoms to worsen; call a poison control center or emergency services right away.

Therapeutic Uses of Ciprocure

What Ciprocure Treats: Main Uses and Benefits

Ciprocure is commonly used to help with bacterial infections. This medication is relevant across therapeutic domains such as the urinary tract, lower respiratory tract, and the digestive system, among others. Its use is indicated in clinical settings that involve acute or disruptive symptom patterns due to bacterial infection.

It helps address symptom clusters that may become intense or disruptive, such as fever, pain, and localized discomfort often associated with bacterial disease. This provides support that helps ease the overall symptom burden and contributes to improved day-to-day comfort during symptomatic periods.

This medication is generally considered relevant in conditions characterized by periods of heightened symptoms, such as acute episodes of infectious diarrhea or complicated urinary tract infections. It is applied during phases of increased distress or discomfort when the patient may benefit from assistance in managing the infection.

Benefit Focus: Relief for Fever and Pain

The medication is used to support functional stability and assist patients during episodes of heightened discomfort by targeting the underlying infectious cause.

Eligibility and Restrictions for Use

Who Can and Cannot Use Ciprocure?

The population eligibility for Ciprocure (Ciprofloxacin) is strictly defined by regulatory authorities and is classified by absolute prohibitions and restrictions based on age, physiological status, and underlying health conditions.


Absolute Contraindications (Must Not Use)

Category Regulatory Status
Hypersensitivity Individuals with a documented allergy to Ciprofloxacin or any other fluoroquinolone antibiotic are contraindicated.
Concomitant Drug Use Patients currently receiving Tizanidine must not use Ciprocure.
Comorbidity Use is avoided in patients with a history of Myasthenia Gravis.

Conditional and Restricted Eligibility

Category Official Regulatory Status
Age (Adults) Generally approved for adults (ge 18 years).
Age (Pediatric) Not Recommended as a first-line agent. Use is restricted to specific, severe infections (e.g., Complicated UTI) due to the documented risk of joint issues.
Reproductive Status Not Recommended during pregnancy or breastfeeding due to potential risks.
Organ Function Patients with severe renal impairment require mandatory dosage adjustment. Caution is required in patients with impaired hepatic function or a risk of QT interval prolongation.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

Official regulatory information for Ciprocure (Ciprofloxacin) documents several clinically significant interactions, categorized by their mechanism and resulting constraint.

Classification Interacting Product or Category Official Interaction Constraint
Contraindicated Tizanidine Concomitant administration is formally prohibited due to increased Tizanidine exposure (up to 10-fold), risking severe hypotension.
Clearance Alteration Theophylline The combination should be avoided due to decreased Theophylline clearance, which can lead to elevated serum levels and serious reactions.
PK Inhibition CYP1A2 Substrates (e.g., Caffeine, Methotrexate, Clozapine) Ciprofloxacin is documented as an inhibitor of CYP1A2 metabolism, resulting in increased systemic concentrations of co-administered drugs metabolized by this pathway.
Absorption Interference Multivalent Cation-Containing Products (e.g., Antacids, Iron, Zinc, Didanosine) These products significantly reduce Ciprofloxacin absorption via chelation. The regulatory mandate is to separate administration by at least 2 hours before or 6 hours after Ciprofloxacin.
Pharmacodynamic Warfarin The anticoagulant effect is officially enhanced, requiring close monitoring (e.g., INR) of the patient's coagulation status.
Population-Specific Corticosteroids in Elderly Patients Official labeling notes an increased risk of severe tendon disorders when Ciprofloxacin and corticosteroids are co-administered in the geriatric population.

Co-administration with Probenecid is documented to reduce Ciprofloxacin's renal clearance, which increases its concentration in the systemic circulation by approximately 50%. The use of Ciprofloxacin with other agents that prolong the QT interval (e.g., Class IA and III antiarrhythmics) is noted to increase the risk of serious cardiac rhythm changes.

Mechanism of Action

Ciprofloxacin's mechanism of action involves a bactericidal effect resulting from intervention in core bacterial genetic processes.

Targeting Bacterial Genetic Torsional Management

Ciprofloxacin functions as an inhibitor of two critical microbial enzymes: DNA Gyrase (Topoisomerase II) and Topoisomerase IV. The drug binds to and stabilizes the enzyme-DNA complex, critically preventing the enzymes from re-ligating the bacterial DNA strands after they are cut. This specific molecular interaction directly disrupts the bacterial cell's ability to manage the physical strain (torsion) necessary for DNA replication, transcription, and chromosome separation.

Initiating a Lethal Cellular Cascade

By preventing DNA re-ligation, the drug forces the accumulation of overwhelming, irreparable double-strand DNA breaks throughout the bacterial genome. This extensive genetic fragmentation triggers the bacterial SOS stress response, which, when faced with damage beyond repair, initiates a rapid self-destruction pathway known as bacteriolysis. This lethal cascade results in the mass death and subsequent clearance of susceptible microbial cells.

Biological Constraints on Functional Action

Bacteria may develop point mutations in the genes encoding the target enzymes (gyrA, parC), which structurally alter the binding site and reduce the inhibitory affinity of the drug. Furthermore, the overexpression of active membrane-bound efflux pumps can physically expel Ciprofloxacin from the cell, lowering its effective concentration below the required bactericidal threshold.

Dosage and Administration Information

Administration Protocol for Ciprocure

The use of Ciprocure (Ciprofloxacin) is guided by established instructions that define the route, frequency, dose, and administration conditions for the medication.

Instruction Domain General Administration Guidance
Routes and Forms Administered via the oral route (tablets or suspension), as an intravenous (IV) infusion, or through topical ophthalmic/otic drops. Oral doses for adults range from 250 mg to 750 mg per dose, while IV doses typically range from 200 mg to 400 mg per dose.
Standard Frequency Dosing is usually administered every 12 hours (twice daily) for immediate-release forms and IV infusion, or once daily for extended-release tablets. The full course is intended to be completed over a defined duration, ranging from short courses of 3 days up to 60 days or more.
Ingestion Conditions Oral forms may be taken with or without food; however, they must not be taken alone with dairy products (such as milk or yogurt) or beverages fortified with calcium. The administration should be separated by several hours from these products.
Special Handling Extended-release tablets must be swallowed whole and are not designed to be crushed, split, or chewed. The IV solution requires administration as a slow infusion over 30 to 60 minutes.
Adjustments Dose adjustments are required for adult patients with renal impairment based on their kidney function metrics. Pediatric use requires weight-based calculations.

The standardized protocol is structured by these explicit instructions, which ensure consistent delivery of the medicine. The administration is dictated by a fixed duration and frequency, with specific requirements for ingestion and handling that are followed according to specified product parameters.

Recent Clinical Evidence

Research evidence / Overview of studies for Ciprocure

1. Evidence for Use in Systemic Infections (Urinary, Respiratory, and Intra-Abdominal)

The research foundation for Ciprocure in core systemic infections is based on a large volume of comparative studies evaluated against established criteria. This area was studied for conditions characterized by acute or disruptive episodes in the urinary tract, lower respiratory tract, and digestive system. The bulk of the evidence comes from Randomized Controlled Trials (RCTs), where the drug was evaluated in specific patient groups against a comparator, such as an inactive substance (placebo) or an alternative treatment regimen.

These studies focused on measuring microbiological outcomes, specifically tracking the clearance of bacteria from the infection site, as well as clinical outcomes related to physical discomfort, such as the tracking of symptom changes related to fever and localized pain. The methodological quality of the trials is described as High, reflecting the established research standards used. A key limitation that research monitors is antimicrobial resistance. Regulatory bodies and researchers continue to monitor how resistance develops in common bacteria, which may influence the effectiveness patterns observed in some studies over time. Therefore, data show patterns related to the current resistance context.


2. Research Evidence for Localized and Specialized Infections

Research has also examined Ciprocure in specialized forms and for infections in specific body parts. This includes trials using ophthalmic drops for eye infections and otic preparations for the ear, as well as studies for conditions like chronic bacterial prostatitis and bone and joint infections. The evidence for these uses is typically derived from targeted RCTs against a comparator substance or regimen.

Studies monitored outcomes related to systemic or functional imbalance, such as the changes in bacterial load measurements in tissue or fluid, and outcomes tracking changes in local symptoms. The evidence is limited for some of these specialized indications. For instance, the sample sizes were modest in some studies looking at specific, less common infections, and the certainty remains low for some of the more complex scenarios.


3. Long-Term Studies and Follow-Up Data

While primary trials focused on short-term symptom patterns, some research also explored outcomes reflecting daily functioning or activity level over longer periods. For example, some observational cohorts have tracked patients for up to one year to monitor parameters related to episodic or acute changes. Despite this, there is limited information for long-term outcomes regarding the complete durability of the microbiological response for every indication. The long-term effects are not fully established beyond the initial assessment periods for some populations.

Key Studies & References

  1. Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study

Frequently Asked Questions (FAQ)

Common questions about Ciprocure (FAQ)


Q: How long does Ciprocure stay in your system?

A: The official product information indicates that the drug’s elimination from the body takes a short period of time. In patients with typical kidney function, the medicine has a serum elimination half-life of approximately 4 hours. Most of the drug is typically cleared through the urine within 24 hours after the last dose.


Q: Does Ciprocure affect fertility?

A: Official research has not established whether using Ciprofloxacin affects the ability of men or women to conceive (get pregnant). Studies focusing specifically on this topic in humans are limited, and specific claims about effects on human fertility are not established within the available regulatory data.


Q: Are there known allergic reactions to Ciprocure?

A: Yes, regulatory documents note that individuals with a documented allergy (known as hypersensitivity) to Ciprofloxacin or any other drug in the fluoroquinolone class are contraindicated from using this medicine. Documented allergic responses can range from a mild rash to severe, systemic reactions.


Q: Will Ciprocure change my mood or mental state?

A: Regulatory documents state that Ciprofloxacin may cause Central Nervous System (CNS) events. These documented effects include confusion, dizziness, depression, anxiety, agitation, hallucinations, and, rarely, suicidal thoughts or psychosis. These effects are documented in official safety information.


Q: What happens if I miss a dose of Ciprocure?

A: The standard instruction in official patient information is to take the missed dose as soon as it is remembered. However, if it is nearly time for the next scheduled dose, regulatory advice states that the missed dose should be skipped, and the regular dosing schedule should be resumed without taking two doses at once.


Q: Is Ciprocure used for pain relief?

A: Ciprocure is classified as an antimicrobial agent and a fluoroquinolone antibiotic. Its official purpose is strictly to treat infections caused by susceptible bacteria. It is not approved or indicated for use as a general pain-relieving medication.


Q: Does Ciprocure cause issues with blood sugar levels?

A: Regulatory documents include both hyperglycemia (high blood sugar) and hypoglycemia (low blood sugar) among the possible serious adverse effects reported for fluoroquinolone antibiotics. The official documentation notes this risk, particularly when the drug is used with other medications that affect blood sugar.


Q: Can Ciprocure be crushed or split?

A: Official administration instructions specify that extended-release tablets must be swallowed whole and should not be crushed, split, or chewed. While immediate-release tablets are sometimes altered, regulatory information prefers that they be taken whole to ensure consistent delivery of the medicine.


Q: Does Ciprocure have restrictions related to driving or operating machinery?

A: Official warnings note that Ciprofloxacin may cause certain side effects, such as dizziness, light-headedness, or headache. The warning requires individuals to consider how the drug affects them before performing activities such as driving or operating machinery.


Q: How quickly should I expect to feel the effects of Ciprocure?

A: Clinical trials tracked changes in symptoms to monitor clinical outcomes related to infection. However, official regulatory documents do not provide a specific, general timeline for when an individual patient should expect to notice the first effects of the medicine.


Q: Will Ciprocure affect my sleep?

A: While official documents cite various Central Nervous System (CNS) effects, insomnia (difficulty sleeping) has also been reported as an adverse effect of Ciprofloxacin. This effect is noted in the official adverse event reporting data.


Q: Can I drink coffee while taking Ciprocure?

A: Ciprofloxacin is documented to inhibit the metabolism of certain substances, including Caffeine, which is present in coffee. This mechanism means that increased concentrations of caffeine in the body may result, which can be associated with symptoms like nervousness or heart palpitations.


Q: Are there any specific foods to avoid when using Ciprocure?

A: Official administration instructions state that oral forms must not be taken alone with dairy products (such as milk or yogurt) or beverages fortified with calcium. These products can significantly reduce the absorption of Ciprofloxacin into the bloodstream.


Q: Can Ciprocure be used during pregnancy?

A: Ciprocure is not generally recommended for use during pregnancy or breastfeeding, as noted in official regulatory information. This is due to documented risks, and its use is considered only in situations where the potential benefit is judged to outweigh the documented risks.


Q: Are there different strengths or dosages of Ciprocure?

A: Yes, official labeling confirms that Ciprocure is available in several different strengths across its various forms. These forms include tablets (e.g., 250 mg, 500 mg, 750 mg), extended-release tablets (e.g., 500 mg, 1000 mg), and specialized solutions for intravenous (IV) administration.


Q: Does taking Ciprocure make you sensitive to the sun?

A: The official warnings note that this drug is associated with a risk of photosensitivity reactions. Regulatory warnings state that exposure to the sun and artificial ultraviolet (UV) light sources should be limited or avoided to reduce the risk of severe sunburn.


Q: Will Ciprocure interfere with my birth control pills?

A: Official sources generally indicate that Ciprofloxacin does not directly affect the intended function of hormonal contraception, including birth control pills. However, if the medicine causes vomiting or severe diarrhea, the effectiveness of oral contraceptives may be indirectly reduced.


Q: Does alcohol interact with Ciprocure?

A: Official regulatory documents do not contain an absolute prohibition against consuming alcohol while taking Ciprofloxacin. However, alcohol may compound and worsen certain potential side effects of the drug, such as dizziness, nausea, and drowsiness.


Q: Will Ciprocure interfere with common pain relievers like ibuprofen?

A: Official warnings note that taking Ciprofloxacin with some nonsteroidal anti-inflammatory drugs (NSAIDs), such as Ibuprofen, is associated with an increased risk of Central Nervous System stimulation. This stimulation can potentially lead to excitability or, rarely, seizures.


Q: What are the general guidelines for who is eligible to use Ciprocure?

A: Eligibility is strictly defined in regulatory documents. Key restrictions include absolute prohibitions for individuals with hypersensitivity to fluoroquinolones and those taking Tizanidine. Use is also restricted or generally not recommended for children, pregnant or breastfeeding women, and those with certain pre-existing conditions like severe kidney impairment.

How should Ciprocure be stored and disposed of?

How to Store and Dispose of Ciprocure?

Ciprocure (ciprofloxacin) must be stored according to official regulatory specifications to maintain its stability.


️ Storage Requirements

Tablets must be stored at 20 C to 25 C (68 F to 77 F) in a tightly closed container.

Oral Suspension (Unmixed) must be stored below 30 C and must not be frozen. Once reconstituted, the suspension is stable for up to 14 days when stored at room temperature or refrigerated, but still must not be frozen.

Injection (IV) must be stored between 5 C and 30 C (41 F and 86 F), protected from light, and freezing must be avoided.

Child Safety: All forms must be kept out of the sight and reach of children.


️ Disposal Instructions

Unused or expired Ciprocure must not be disposed of via wastewater or household waste. The product should be returned to a pharmacy or discarded using official local waste disposal programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ciprocure found in:

A-Z Index: